HN2011001601A - Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- HN2011001601A HN2011001601A HN2011001601A HN2011001601A HN2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A
- Authority
- HN
- Honduras
- Prior art keywords
- morfina
- therapeutics
- derivatives
- application
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/06—Heterocyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ESTA INVENCION SE REFIERE A DERIVADOS DE MORFINA -6-GLUCORONIDO DE FORMULA I SIUIENTE EN LA R1 ES UN GRUPO HETEROAROMATICO DE 5 ESLABONES EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS SUSTITUYENTES ELEGIDOS ENTRE ATOMOS DE HALOGENOS Y LOS GRUPOS ALQUILO (C1-C4) HALOGENO, HIDROXILO, HALOALQUILO (C1-C4), ALQUILOXI (C1-C4), ARIL-ALQUILO (C1-C4) Y ARILO, ESTANDO DICHO GRUPO ARILO EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS GRUPOS ELEGIDOS ENTRE LOS GRUPOS ALQUILO (C1-C4), HALOALQUILO (C1-C4), HIDROXILO Y ALQUILO (C1-C4) EN FORMA DE BASE O SAL DE ADICION A UN ACIDO ASI COOM EN EL ESTADO DE HIDRATO O DE SOLVATO. LA PRESENTE INVENCION TIENE TAMBIEN POR OBJETO SU PROCEDIMIENTO DE PREPARACION Y SU APLICACION EN TERAPEUTICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0806949A FR2939437B1 (fr) | 2008-12-10 | 2008-12-10 | Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2011001601A true HN2011001601A (es) | 2013-09-16 |
Family
ID=41031604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2011001601A HN2011001601A (es) | 2008-12-10 | 2011-06-09 | Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica |
Country Status (30)
Country | Link |
---|---|
US (1) | US8461122B2 (es) |
EP (1) | EP2376512B1 (es) |
JP (1) | JP5616356B2 (es) |
KR (1) | KR20110104486A (es) |
CN (1) | CN102317301B (es) |
AR (1) | AR074514A1 (es) |
AU (1) | AU2009326909B2 (es) |
BR (1) | BRPI0922733A2 (es) |
CA (1) | CA2746429A1 (es) |
CL (1) | CL2011001399A1 (es) |
CR (1) | CR20110306A (es) |
EA (1) | EA019053B1 (es) |
EC (1) | ECSP11011110A (es) |
ES (1) | ES2468990T3 (es) |
FR (1) | FR2939437B1 (es) |
HK (1) | HK1163110A1 (es) |
HN (1) | HN2011001601A (es) |
IL (1) | IL213381A (es) |
MA (1) | MA32952B1 (es) |
MX (1) | MX2011006252A (es) |
MY (1) | MY152978A (es) |
NI (1) | NI201100115A (es) |
NZ (1) | NZ593344A (es) |
PE (1) | PE20120260A1 (es) |
SG (1) | SG172068A1 (es) |
TN (1) | TN2011000266A1 (es) |
TW (1) | TW201026312A (es) |
UA (1) | UA104302C2 (es) |
WO (1) | WO2010067010A2 (es) |
ZA (1) | ZA201104305B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103421063B (zh) * | 2012-05-23 | 2016-04-06 | 宜昌人福药业有限责任公司 | 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法 |
CN111346104B (zh) * | 2018-12-21 | 2022-06-10 | 宜昌人福药业有限责任公司 | 一种吗啡-6-葡萄糖醛酸苷透皮给药的药物组合物及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3766188A (en) | 1971-06-28 | 1973-10-16 | Yamanouchi Pharma Co Ltd | Carbonyldioxymorphinan derivatives |
GB9116909D0 (en) | 1991-08-06 | 1991-09-18 | Salford Ultrafine Chem & Res | Morphine derivatives |
GB2282758A (en) | 1993-08-23 | 1995-04-19 | Euro Celtique Sa | Oral morphine-6-glucuronide compositions |
ES2201482T3 (es) * | 1997-04-14 | 2004-03-16 | Ufc Limited | Derivados de la morfina. |
HUP0102333A3 (en) | 1998-06-06 | 2003-07-28 | Cenes Ltd Cambridge | Morphine-6-glucuronide synthesis |
GB0218811D0 (en) * | 2002-08-14 | 2002-09-18 | Cenes Ltd | Salts of morphine-6-glucuronide |
FR2864082B1 (fr) * | 2003-12-22 | 2006-03-10 | Synt Em | Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur |
EP1758452B1 (en) * | 2004-05-28 | 2017-01-25 | Human Biomolecular Research Institute | Metabolically stable analgesics and pain medications |
FR2907121B1 (fr) * | 2006-10-12 | 2012-05-04 | Neorphys | Nouveaux derives morphiniques |
-
2008
- 2008-12-10 FR FR0806949A patent/FR2939437B1/fr not_active Expired - Fee Related
-
2009
- 2009-12-08 JP JP2011540163A patent/JP5616356B2/ja not_active Expired - Fee Related
- 2009-12-08 WO PCT/FR2009/052448 patent/WO2010067010A2/fr active Application Filing
- 2009-12-08 UA UAA201108592A patent/UA104302C2/ru unknown
- 2009-12-08 SG SG2011042314A patent/SG172068A1/en unknown
- 2009-12-08 PE PE2011001199A patent/PE20120260A1/es not_active Application Discontinuation
- 2009-12-08 MX MX2011006252A patent/MX2011006252A/es active IP Right Grant
- 2009-12-08 CN CN200980156457.9A patent/CN102317301B/zh not_active Expired - Fee Related
- 2009-12-08 MY MYPI20112600 patent/MY152978A/en unknown
- 2009-12-08 ES ES09801748.6T patent/ES2468990T3/es active Active
- 2009-12-08 CA CA2746429A patent/CA2746429A1/fr not_active Abandoned
- 2009-12-08 NZ NZ593344A patent/NZ593344A/xx not_active IP Right Cessation
- 2009-12-08 BR BRPI0922733A patent/BRPI0922733A2/pt not_active IP Right Cessation
- 2009-12-08 AU AU2009326909A patent/AU2009326909B2/en not_active Ceased
- 2009-12-08 MA MA33999A patent/MA32952B1/fr unknown
- 2009-12-08 EA EA201170792A patent/EA019053B1/ru not_active IP Right Cessation
- 2009-12-08 KR KR1020117013142A patent/KR20110104486A/ko not_active Application Discontinuation
- 2009-12-08 EP EP09801748.6A patent/EP2376512B1/fr active Active
- 2009-12-09 AR ARP090104752A patent/AR074514A1/es unknown
- 2009-12-09 TW TW098142109A patent/TW201026312A/zh unknown
-
2011
- 2011-05-24 TN TN2011000266A patent/TN2011000266A1/fr unknown
- 2011-06-05 IL IL213381A patent/IL213381A/en not_active IP Right Cessation
- 2011-06-06 EC EC2011011110A patent/ECSP11011110A/es unknown
- 2011-06-06 CR CR20110306A patent/CR20110306A/es not_active Application Discontinuation
- 2011-06-08 US US13/155,655 patent/US8461122B2/en not_active Expired - Fee Related
- 2011-06-08 NI NI201100115A patent/NI201100115A/es unknown
- 2011-06-09 CL CL2011001399A patent/CL2011001399A1/es unknown
- 2011-06-09 HN HN2011001601A patent/HN2011001601A/es unknown
- 2011-06-09 ZA ZA2011/04305A patent/ZA201104305B/en unknown
-
2012
- 2012-04-18 HK HK12103829.7A patent/HK1163110A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32606A (es) | Sulfonamidas nematocidas | |
CR20190168A (es) | Compuestos de benzo[b]tiofeno como agonistas de sting | |
AR111811A2 (es) | Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos | |
AR075084A1 (es) | Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes | |
PE20131343A1 (es) | Derivados de acido benzoico | |
CL2009000650A1 (es) | Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras | |
DK1893587T3 (da) | Fremgangsmåde til fremstilling af dihydroquinazoliner | |
CL2009000142A1 (es) | Composicion liquida monocomponente con un contenido de fluor con respecto a la resina solida de 5 a 75% en peso para el tratamiento permanente de superficies de sustratos porosos y no porosos; procedimiento para la obtencion de composiciones que contienen fluor; y uso de dichas composiciones. | |
ECSP10010688A (es) | Activadores de glucoquinasa | |
MX343596B (es) | Sulfonamidas nematocidas. | |
ECSP12012161A (es) | Compuestos en calidad de antagonistas de Bradiquinina-b1 | |
BR112017008176A2 (pt) | método de preparação do carbonato de ácido glicérico. | |
PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
CL2018002674A1 (es) | Una composición de componente único o múltiple para la producción de un hidrogel | |
UY29749A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, así como su uso como medicamentos | |
CO6331307A2 (es) | Derivados de imidazo[1,2alfa]piridin-2-carboxamidas su preparacion y su aplicacion en terapeutica | |
CO6251235A2 (es) | Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica | |
BR112015031293A2 (pt) | politiol, composição para materiais ópticos, material óptico, e, lente | |
AR070874A1 (es) | Compuesto heterociclico fusionado, una composicion farmaceutica que lo comprende y su uso en el tratamiento del cancer. | |
HN2011001601A (es) | Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica | |
EA201490360A1 (ru) | Композиции, содержащие соли аминокислот | |
CO6612193A2 (es) | Octasacàridos n-acilos activadores de los receptores de los fgf su preparación y su aplicación en terapéutica | |
CO6251292A2 (es) | Nuevos derivados 7-sustituidos de 3-carboxi-oxadiacino-quinolonas, su preparacion y su aplicacion como antibacterianos. | |
CO6321242A2 (es) | Compuestos de n-fenil-imidazo[1,2-alfa]piridin-2-carboxamidas su preparacion y su aplicacion en terapeutica |